Abstract
Nociceptin opioid peptide receptor agonists interact with mu-opioid receptor agonists for pain relief. A new study by Ding et al. (2018) examines a bifunctional nociceptin- and mu-opioid receptor agonist, AT-121, that provides analgesia without physiological side effects or abuse liability, offering a promising new hope toward better analgesics.
Original language | English |
---|---|
Pages (from-to) | 1280-1282 |
Number of pages | 3 |
Journal | Neuron |
Volume | 100 |
Issue number | 6 |
DOIs | |
State | Published - Dec 19 2018 |